Skip to main content Back to Top
Advertisement

2/6/2023

Fluorouracil Injection

Products Affected - Description

    • Fluorouracil injection, Fresenius Kabi, 50 mg/mL, 10 mL vial, 10 count, NDC 63323-0117-10
    • Fluorouracil injection, Fresenius Kabi, 50 mg/mL, 100 mL vial, 1 count, NDC 63323-0117-61
    • Fluorouracil injection, Fresenius Kabi, 50 mg/mL, 20 mL vial, 10 count, NDC 63323-0117-20
    • Fluorouracil injection, Fresenius Kabi, 50 mg/mL, 50 mL vial, 1 count, NDC 63323-0117-51
    • Fluorouracil injection, Sagent, 50 mg/mL, 100 mL vial, 1 count, NDC 25021-1215-99
    • Fluorouracil injection, Sagent, 50 mg/mL, 50 mL vial, 1 count, NDC 25021-1215-98

Reason for the Shortage

    • Accord has not provided us any availability updates at this time.
    • Fresenius Kabi has fluorouracil injection on shortage due to increased demand.
    • Sagent did not provide a reason for the shortage.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Fresenius Kabi has fluorouracil 50 mg/mL 10 mL, 20 mL, 50 mL, and 100 mL vials on back order and the company estimates a release date of mid-February 2023 for the 10 mL vials, late-February 2023 for the 20 mL vials, late-February to early-March 2023 for the 50 mL vials, and early-February 2023 for the 100 mL vials.
    • Sagent has fluorouracil 50 mg/mL 50 mL and 100 mL vials on back order and the company estimates a release date of March 2023.

Updated

Updated February 6, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 9, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.